Hostname: page-component-78c5997874-94fs2 Total loading time: 0 Render date: 2024-11-09T19:12:40.766Z Has data issue: false hasContentIssue false

EPA-1301 - Neurobiological Factors in Suicidal Behavior in Patients with Depressive Disorders

Published online by Cambridge University Press:  15 April 2020

V. Korostiy
Affiliation:
Psychyatry Narcology and Medical Psychology, Kharkiv National Medical University, Kharkov, Ukraine
A. Kozhyna
Affiliation:
Psychyatry Narcology and Medical Psychology, Kharkiv National Medical University, Kharkov, Ukraine
K. Zelenskaya
Affiliation:
Psychyatry Narcology and Medical Psychology, Kharkiv National Medical University, Kharkov, Ukraine

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction:

Suicide is a major cause of disability and mortality.

Aims:

Examine the role of neurobiological factors of suicidal behavior, includingneyrotransmitternyh and neurohormonal systems, which include the metabolism ofbiogenic amines.

Objectives:

55patients aged 17 - 35 years of both sexes (58 men and 97 women) who havecommitted suicide

Methods:

Clinicalexamination, biochemical and immunogenetical methods.

Results:

Found thattheir violation and imbalance, namely increased concentrations of serotonin inthe blood (2,39 ± 0,24 mmol / l) reduction in plasma melatonin (0,71 ± 0,07 mmol / l) and decreasedexcretion rate adrenaline and noradrenaline at night (0,39 ± 0,06 and 1,21 ± 0,25 mmol / h) and daytime periods(1,66 ± 0,26and 4,56 ± 0,86 mmol/ h), creates neurohormonal background for the development of psychopathologicalconditions that lead to suicidal intentions and actions.

Conclusions:

Patientswith specified neurobiological changes have been unable to get out of the longconflict through active variant of overcoming conflict and completed suicidalacts. According to the results of biomedical research, with to appropriatecorrection is differentiated use of natural biogenic stimulants herbalantidepressant that selectively affect the turnover of serotonin, melatonin, or drugs that stimulate the function of epiphysis.

Type
P14 - Genetics & Molecular Neurobiology
Copyright
Copyright © European Psychiatric Association 2014
Submit a response

Comments

No Comments have been published for this article.